Molecular Glue Degraders for Non-Oncology Indications

Time: 9:00 am
day: Day 2 AM


  • Molecular glue degraders (MGDs) have historically been developed for oncology indications
  • Our platform has enabled programs in non-oncology indications, such as diseases associated with autoimmunity and inflammation
  • An overview of the additional challenges associated with degraders for non-oncology diseases will be provided, together with updates on our programs highlighting our rational design of selective and orally active MGDs